Opko Health, Inc. OPK
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 65.41M | 163.58M | 124.20M | 148.45M | 56.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.41M | 163.58M | 124.20M | 148.45M | 56.43M |
| Cost of Revenue | 25.15M | 116.73M | 107.64M | 117.20M | 23.87M |
| Gross Profit | 40.26M | 46.85M | 16.56M | 31.25M | 32.55M |
| SG&A Expenses | 24.84M | 52.92M | 48.61M | 55.22M | 22.27M |
| Depreciation & Amortization | 16.46M | 18.97M | 18.97M | 19.06M | 16.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.82M | 188.62M | 175.21M | 191.47M | 89.98M |
| Operating Income | -31.41M | -25.04M | -51.02M | -43.02M | -33.55M |
| Income Before Tax | -42.87M | -13.40M | -60.96M | -46.92M | -40.97M |
| Income Tax Expenses | -7.31M | -4.98M | -6.11M | -15.66M | -8.05M |
| Earnings from Continuing Operations | -35.56M | -8.42M | -54.85M | -31.26M | -32.92M |
| Earnings from Discontinued Operations | -17.98M | -- | -- | -- | 54.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.53M | -8.42M | -54.85M | -31.26M | 21.63M |
| EBIT | -31.41M | -25.04M | -51.02M | -43.02M | -33.55M |
| EBITDA | -8.68M | -2.63M | -28.82M | -20.64M | -10.81M |
| EPS Basic | -0.07 | -0.01 | -0.07 | -0.04 | 0.03 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.05 | -0.04 | -0.03 |
| EPS Diluted | -0.07 | -0.01 | -0.07 | -0.04 | 0.03 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.05 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 746.48M | 755.27M | 758.88M | 765.52M | 777.15M |
| Average Diluted Shares Outstanding | 746.48M | 755.27M | 758.88M | 765.52M | 777.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |